Cargando…
Meta‐Analysis of Intensive Lipid‐Lowering Therapy in Patients With Polyvascular Disease
BACKGROUND: Polyvascular atherosclerotic disease is associated with an increased risk of future cardiovascular events. Intensive lipid‐lowering therapy (ILT) may mitigate this risk. The aims of this study‐level meta‐analysis were to examine the effects of ILT in patients with polyvascular disease an...
Autores principales: | Alkhalil, Mohammad, Kuzemczak, Michał, Whitehead, Nicholas, Kavvouras, Charalampos, Džavík, Vladimír |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174253/ https://www.ncbi.nlm.nih.gov/pubmed/33586467 http://dx.doi.org/10.1161/JAHA.120.017948 |
Ejemplares similares
-
ACE inhibitor-related angioedema in a COVID-19 patient—a plausible contribution of the viral infection?
por: Kuzemczak, Michał, et al.
Publicado: (2021) -
Multivessel coronary thrombosis in a COVID-19 patient: Lungs are not always a culprit
por: Kuzemczak, Michał, et al.
Publicado: (2021) -
Intensity of Lipid-Lowering Therapy Among Patients With Polyvascular Disease
por: Peterson, Benjamin E., et al.
Publicado: (2023) -
Bridging the Racial Disparity Gap in Lipid‐Lowering Therapy
por: Kalra, Dinesh K.
Publicado: (2020) -
Association of Lowering Low‐Density Lipoprotein Cholesterol With Contemporary Lipid‐Lowering Therapies and Risk of Diabetes Mellitus: A Systematic Review and Meta‐Analysis
por: Khan, Safi U., et al.
Publicado: (2019)